{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:47:30Z","timestamp":1782200850448,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["23FC1048"],"award-info":[{"award-number":["23FC1048"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["24K11440"],"award-info":[{"award-number":["24K11440"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010391","name":"Tokyo Women's Medical University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010391","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Anemia is less prevalent in autosomal dominant polycystic kidney disease (ADPKD) owing to preserved erythropoietin production. However, its impact on kidney prognosis remains unclear. Given sex-related differences in hemoglobin (Hb) levels, we hypothesized that the prognostic relevance of anemia may vary by sex and age. Therefore, we aimed to identify subgroup-specific risk patterns using an attribute-based cross-classification approach to support individualized anemia management in ADPKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed 552 Japanese patients with ADPKD from a single-center cohort. The primary outcome was a\u2009\u2265\u200930% decline in the estimated glomerular filtration rate (eGFR) or initiation of renal replacement therapy. Cox regression analysis was used to assess the association between Hb and kidney outcomes. Subgroup analyses were performed using cross-classification by sex and age (&lt;\u200950 or\u2009\u2265\u200950\u00a0years). Anemia was defined using multiple Hb thresholds (&lt;\u200911,\u2009&lt;\u200912, and\u2009&lt;\u200913\u00a0g\/dL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Lower Hb levels were independently associated with worse renal outcomes (hazard ratio [HR] per 1\u00a0g\/dL increase: 0.83). Cross-classified analyses revealed distinct risk patterns. Anemia (Hb level\u2009&lt;\u200913.0\u00a0g\/dL) significantly increased the risk in young (HR: 2.92) and old men (HR: 3.84). In women, anemia defined as a Hb level\u2009&lt;\u200912.0\u00a0g\/dL was associated with adverse outcomes in both age groups (HR: 1.98 in\u2009&lt;\u200950\u00a0years; HR: 2.08 in\u2009\u2265\u200950\u00a0years).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Anemia is a significant prognostic marker for kidney disease progression in ADPKD. Its prognostic impact differs by sex and age, suggesting the need for attribute-based, individualized hemoglobin thresholds rather than uniform cutoffs, to optimize risk stratification and clinical assessment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10157-026-02867-0","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:24:11Z","timestamp":1777472651000},"page":"1091-1100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Attribute-based cross-classification reveals sex- and age-specific prognostic impact of anemia in ADPKD"],"prefix":"10.1007","volume":"30","author":[{"given":"Kosaku","family":"Nitta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9543-7608","authenticated-orcid":false,"given":"Hiroshi","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Ushio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Manabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiho","family":"Makabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Otsubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Hanafusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"2867_CR1","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1007\/s10157-012-0611-9","volume":"16","author":"E Higashihara","year":"2012","unstructured":"Higashihara E, Horie S, Muto S, Mochizuki T, Nishio S, Nutahara K. Renal disease progression in autosomal dominant polycystic kidney disease. Clin Exp Nephrol. 2012;16:622\u20138.","journal-title":"Clin Exp Nephrol"},{"key":"2867_CR2","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12882-015-0114-5","volume":"16","author":"C Woon","year":"2015","unstructured":"Woon C, Bielinski-Bradbury A, O\u2019Reilly K, Robinson P. A systematic review of the predictors of disease progression in patients with autosomal dominant polycystic kidney disease. BMC Nephrol. 2015;16:140.","journal-title":"BMC Nephrol"},{"issue":"1","key":"2867_CR3","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3390\/jcm9010146","volume":"9","author":"H Kataoka","year":"2020","unstructured":"Kataoka H, Fukuoka H, Makabe S, Yoshida R, Teraoka A, Ushio Y, et al. Prediction of Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease Using PKD1\/PKD2 Mutations. J clin med. 2020;9(1):146.","journal-title":"J clin med"},{"key":"2867_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-024-02568-6","author":"K Nitta","year":"2024","unstructured":"Nitta K, Kataoka H, Manabe S, Makabe S, Akihisa T, Ushio Y, et al. Association of hyperphosphatemia with renal prognosis in patients with autosomal dominant polycystic kidney disease. Clin Exp Nephrol. 2024. https:\/\/doi.org\/10.1007\/s10157-024-02568-6.","journal-title":"Clin Exp Nephrol"},{"key":"2867_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0215920","volume":"14","author":"SW Yi","year":"2019","unstructured":"Yi SW, Moon SJ, Yi JJ. Low-normal hemoglobin levels and anemia are associated with increased risk of end-stage renal disease in general populations: a prospective cohort study. PLoS ONE. 2019;14:e0215920.","journal-title":"PLoS ONE"},{"issue":"1","key":"2867_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2369-14-2","volume":"14","author":"J Portoles","year":"2013","unstructured":"Portoles J, Gorriz JL, Rubio E, de Alvaro F, Garcia F, Alvarez-Chivas V, et al. The development of anemia is associated to poor prognosis in NKF\/KDOQI stage 3 chronic kidney disease. BMC Nephrol. 2013;14(1):2.","journal-title":"BMC Nephrol"},{"key":"2867_CR7","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1053\/j.jrn.2019.11.003","volume":"30","author":"J Hoshino","year":"2020","unstructured":"Hoshino J, Muenz D, Zee J, Sukul N, Speyer E, Guedes M, et al. Associations of hemoglobin levels with health-related quality of life, physical activity, and clinical outcomes in persons with stage 3\u20135 nondialysis CKD. J Ren Nutr. 2020;30:404\u201314.","journal-title":"J Ren Nutr"},{"key":"2867_CR8","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ndt\/gfm717","volume":"23","author":"EA de Almeida","year":"2008","unstructured":"de Almeida EA, Alho I, Marques F, Thiran C, Bicho MP, Prata M. Haemoglobin and erythropoietin levels in polycystic kidney disease. Nephrol, Dial, Transplant: Off Publ Euro Dial Transplant Assoc\u2014Euro Renal Assoc. 2008;23:412\u20133.","journal-title":"Nephrol, Dial, Transplant: Off Publ Euro Dial Transplant Assoc\u2014Euro Renal Assoc"},{"key":"2867_CR9","first-page":"26","volume":"39","author":"M Chandra","year":"1985","unstructured":"Chandra M, Miller ME, Garcia JF, Mossey RT, McVicar M. Serum immunoreactive erythropoietin levels in patients with polycystic kidney disease as compared with other hemodialysis patients. Nephron. 1985;39:26\u20139.","journal-title":"Nephron"},{"key":"2867_CR10","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1172\/JCI114280","volume":"84","author":"KU Eckardt","year":"1989","unstructured":"Eckardt KU, Mollmann M, Neumann R, Brunkhorst R, Burger HU, Lonnemann G, et al. Erythropoietin in polycystic kidneys. J Clin Investig. 1989;84:1160\u20136.","journal-title":"J Clin Investig"},{"key":"2867_CR11","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s10157-020-01856-1","volume":"24","author":"Y Ushio","year":"2020","unstructured":"Ushio Y, Kataoka H, Sato M, Manabe S, Watanabe S, Akihisa T, et al. Association between anemia and renal prognosis in autosomal dominant polycystic kidney disease: a retrospective study. Clin Exp Nephrol. 2020;24:500\u20138.","journal-title":"Clin Exp Nephrol"},{"key":"2867_CR12","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1159\/000531329","volume":"9","author":"X Wang","year":"2023","unstructured":"Wang X, Zheng R, Liu Z, Qi L, Gu L, Wang X, et al. Development and validation of a nomogram for renal survival prediction in patients with autosomal dominant polycystic kidney disease. Kidney Dis (Basel). 2023;9:398\u2013407.","journal-title":"Kidney Dis (Basel)"},{"key":"2867_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-15-4","volume":"15","author":"JA Sacristan","year":"2015","unstructured":"Sacristan JA. Clinical research and medical care: towards effective and complete integration. BMC Med Res Methodol. 2015;15:4.","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"2867_CR14","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3390\/jpm10040248","volume":"10","author":"H Kataoka","year":"2020","unstructured":"Kataoka H, Ohara M, Mochizuki T, Iwadoh K, Ushio Y, Kawachi K, et al. Sex Differences in Time Series Changes in Pseudo R2 Values Regarding Hyperuricemia in Relation to the Kidney Prognosis. J Personal Med. 2020;10(4):248.","journal-title":"J Personal Med"},{"key":"2867_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k4245","volume":"363","author":"DM Kent","year":"2018","unstructured":"Kent DM, Steyerberg E, van Klaveren D. Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects. BMJ (Clinical research ed). 2018;363:k4245.","journal-title":"BMJ (Clinical research ed)"},{"key":"2867_CR16","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/j.0887-378X.2004.00327.x","volume":"82","author":"RL Kravitz","year":"2004","unstructured":"Kravitz RL, Duan N, Braslow J. Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages. Milbank Q. 2004;82:661\u201387.","journal-title":"Milbank Q"},{"key":"2867_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-11-57","volume":"11","author":"JA Sacristan","year":"2011","unstructured":"Sacristan JA. Exploratory trials, confirmatory observations: a new reasoning model in the era of patient-centered medicine. BMC Med Res Methodol. 2011;11:57.","journal-title":"BMC Med Res Methodol"},{"key":"2867_CR18","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1159\/000501021","volume":"44","author":"H Kataoka","year":"2019","unstructured":"Kataoka H, Ono K, Mochizuki T, Hanafusa N, Imai E, Hishida A, et al. A body mass index-based cross-classification approach for the assessment of prognostic factors in chronic kidney disease progression. Kidney Blood Press Res. 2019;44:362\u201383.","journal-title":"Kidney Blood Press Res"},{"key":"2867_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-07737-9","volume":"12","author":"H Kataoka","year":"2022","unstructured":"Kataoka H, Mochizuki T, Ohara M, Tsuruta Y, Iwasa N, Yoshida R, et al. Urate-lowering therapy for CKD patients with asymptomatic hyperuricemia without proteinuria elucidated by attribute-based research in the FEATHER study. Sci Rep. 2022;12:3784.","journal-title":"Sci Rep"},{"key":"2867_CR20","doi-asserted-by":"publisher","first-page":"1097596","DOI":"10.3389\/fendo.2023.1097596","volume":"14","author":"H Kataoka","year":"2023","unstructured":"Kataoka H, Nitta K, Hoshino J. Visceral fat and attribute-based medicine in chronic kidney disease. Front Endocrinol. 2023;14:1097596.","journal-title":"Front Endocrinol"},{"key":"2867_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-05762-y","volume":"15","author":"H Kataoka","year":"2025","unstructured":"Kataoka H, Hayashi T, Nangaku M, Narita I, Kagimura T, Nitta K, et al. Attribute based cross classification analyses from the BRIGHTEN study reveal that therapeutic responsiveness to erythropoiesis stimulating agents predicts cardiorenal prognosis in renal anemia. Sci Rep. 2025;15:23221.","journal-title":"Sci Rep"},{"issue":"4","key":"2867_CR22","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"Kidney Disease: Improving Global Outcomes CKDWG","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes CKDWG. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4):S117\u2013314.","journal-title":"Kidney Int"},{"key":"2867_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41581-023-00784-z","volume":"20","author":"NC Chesnaye","year":"2024","unstructured":"Chesnaye NC, Carrero JJ, Hecking M, Jager KJ. Differences in the epidemiology, management and outcomes of kidney disease in men and women. Nat Rev Nephrol. 2024;20:7\u201320.","journal-title":"Nat Rev Nephrol"},{"key":"2867_CR24","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41581-024-00840-2","volume":"20","author":"D Mohottige","year":"2024","unstructured":"Mohottige D, Farouk S, Poteat T, Radix A, Witchel SF. Considerations of sex as a binary variable in clinical algorithms. Nat Rev Nephrol. 2024;20:347\u20138.","journal-title":"Nat Rev Nephrol"},{"key":"2867_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6947-13-6","volume":"13","author":"JA Sacristan","year":"2013","unstructured":"Sacristan JA. Patient-centered medicine and patient-oriented research: improving health outcomes for individual patients. BMC Med Inform Decis Mak. 2013;13:6.","journal-title":"BMC Med Inform Decis Mak"},{"key":"2867_CR26","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1007\/s00380-019-01375-4","volume":"34","author":"K Kawachi","year":"2019","unstructured":"Kawachi K, Kataoka H, Manabe S, Mochizuki T, Nitta K. Low HDL cholesterol as a predictor of chronic kidney disease progression: a cross-classification approach and matched cohort analysis. Heart Vessels. 2019;34:1440\u201355.","journal-title":"Heart Vessels"},{"key":"2867_CR27","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1001\/archinte.162.12.1401","volume":"162","author":"BC Astor","year":"2002","unstructured":"Astor BC, Muntner P, Levin A, Eustace JA, Coresh J. Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med. 2002;162:1401\u20138.","journal-title":"Arch Intern Med"},{"key":"2867_CR28","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s10157-023-02432-z","volume":"28","author":"M Nangaku","year":"2024","unstructured":"Nangaku M, Ueta K, Nishimura K, Sasaki K, Hashimoto T. Factors affecting responsiveness of vadadustat in patients with anemia associated with chronic kidney disease: a post-hoc subgroup analysis of Japanese phase 3 randomized studies. Clin Exp Nephrol. 2024;28:391\u2013403.","journal-title":"Clin Exp Nephrol"},{"issue":"10","key":"2867_CR29","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1016\/j.ekir.2023.07.032","volume":"8","author":"M Canney","year":"2023","unstructured":"Canney M, Induruwage D, Tang M, Alencar de Pinho N, Er L, Zhao Y, et al. Regional Variation in Hemoglobin Distribution Among Individuals With CKD: the ISN International Network of CKD Cohorts. Kidney Int Rep. 2023;8(10):2056\u201367.","journal-title":"Kidney Int Rep."},{"key":"2867_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-026-40991-9","author":"H Kataoka","year":"2026","unstructured":"Kataoka H, Ushio Y, Manabe S, Makabe S, Akihisa T, Seki M, et al. Association of anemia with long-term renal prognosis in autosomal dominant polycystic kidney disease using time-series analysis. Sci Rep. 2026. https:\/\/doi.org\/10.1038\/s41598-026-40991-9.","journal-title":"Sci Rep"},{"key":"2867_CR31","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.kint.2021.03.020","volume":"99","author":"JL Babitt","year":"2021","unstructured":"Babitt JL, Eisenga MF, Haase VH, Kshirsagar AV, Levin A, Locatelli F, et al. Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference. Kidney Int. 2021;99:1280\u201395.","journal-title":"Kidney Int"},{"key":"2867_CR32","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1681\/ASN.2008050507","volume":"20","author":"Y Pei","year":"2009","unstructured":"Pei Y, Obaji J, Dupuis A, Paterson AD, Magistroni R, Dicks E, et al. Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol. 2009;20:205\u201312.","journal-title":"J Am Soc Nephrol"},{"key":"2867_CR33","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1681\/ASN.2015010016","volume":"27","author":"E Cornec-Le Gall","year":"2016","unstructured":"Cornec-Le Gall E, Audrezet MP, Rousseau A, Hourmant M, Renaudineau E, Charasse C, et al. The PROPKD score: a new algorithm to predict renal survival in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2016;27:942\u201351.","journal-title":"J Am Soc Nephrol"},{"key":"2867_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-021-02068-x","author":"K Uchiyama","year":"2021","unstructured":"Uchiyama K, Mochizuki T, Shimada Y, Nishio S, Kataoka H, Mitobe M, et al. Factors predicting decline in renal function and kidney volume growth in autosomal dominant polycystic kidney disease: a prospective cohort study (Japanese Polycystic Kidney Disease registry: J-PKD). Clin Exp Nephrol. 2021. https:\/\/doi.org\/10.1007\/s10157-021-02068-x.","journal-title":"Clin Exp Nephrol"},{"key":"2867_CR35","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1111\/bph.12856","volume":"172","author":"MJ Curtis","year":"2015","unstructured":"Curtis MJ, Bond RA, Spina D, Ahluwalia A, Alexander SP, Giembycz MA, et al. Experimental design and analysis and their reporting: new guidance for publication in BJP. Br J Pharmacol. 2015;172:3461\u201371.","journal-title":"Br J Pharmacol"},{"key":"2867_CR36","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/aje\/kwk052","volume":"165","author":"E Vittinghoff","year":"2007","unstructured":"Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007;165:710\u20138.","journal-title":"Am J Epidemiol"},{"key":"2867_CR37","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1056\/NEJMra1011165","volume":"365","author":"GL Semenza","year":"2011","unstructured":"Semenza GL. Oxygen sensing, homeostasis, and disease. N Engl J Med. 2011;365:537\u201347.","journal-title":"N Engl J Med"},{"issue":"5","key":"2867_CR38","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3390\/ijms18050950","volume":"18","author":"J Liu","year":"2017","unstructured":"Liu J, Wei Q, Guo C, Dong G, Liu Y, Tang C, et al. Hypoxia, HIF, and associated signaling networks in chronic kidney disease. Int J Mol Sci. 2017;18(5):950.","journal-title":"Int J Mol Sci"},{"key":"2867_CR39","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.kint.2018.06.008","volume":"94","author":"A Kraus","year":"2018","unstructured":"Kraus A, Peters DJM, Klanke B, Weidemann A, Willam C, Schley G, et al. HIF-1alpha promotes cyst progression in a mouse model of autosomal dominant polycystic kidney disease. Kidney Int. 2018;94:887\u201399.","journal-title":"Kidney Int"},{"key":"2867_CR40","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.kint.2018.07.012","volume":"94","author":"A Hofherr","year":"2018","unstructured":"Hofherr A, Busch T, Kottgen M. HIF-1alpha drives cyst growth in advanced stages of autosomal dominant polycystic kidney disease. Kidney Int. 2018;94:849\u201351.","journal-title":"Kidney Int"},{"key":"2867_CR41","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1681\/ASN.2013030209","volume":"25","author":"B Buchholz","year":"2014","unstructured":"Buchholz B, Schley G, Faria D, Kroening S, Willam C, Schreiber R, et al. Hypoxia-inducible factor-1alpha causes renal cyst expansion through calcium-activated chloride secretion. J Am Soc Nephrol. 2014;25:465\u201374.","journal-title":"J Am Soc Nephrol"},{"key":"2867_CR42","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.blre.2013.12.003","volume":"28","author":"WG Murphy","year":"2014","unstructured":"Murphy WG. The sex difference in haemoglobin levels in adults - mechanisms, causes, and consequences. Blood Rev. 2014;28:41\u20137.","journal-title":"Blood Rev"},{"key":"2867_CR43","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1007\/s10157-021-02029-4","volume":"25","author":"S Manabe","year":"2021","unstructured":"Manabe S, Kataoka H, Mochizuki T, Iwadoh K, Ushio Y, Kawachi K, et al. Impact of visceral fat area in patients with chronic kidney disease. Clin Exp Nephrol. 2021;25:608\u201320.","journal-title":"Clin Exp Nephrol"},{"key":"2867_CR44","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1744-9987.2010.00836.x","volume":"14","author":"Y Tsubakihara","year":"2010","unstructured":"Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, et al. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease. Ther Apher Dial. 2010;14:240\u201375.","journal-title":"Ther Apher Dial"},{"key":"2867_CR45","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s41100-017-0114-y","volume":"3","author":"H Yamamoto","year":"2017","unstructured":"Yamamoto H, Nishi S, Tomo T, Masakane I, Saito K, Nangaku M, et al. 2015 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease. Renal Replace Ther. 2017;3:36.","journal-title":"Renal Replace Ther"},{"issue":"6","key":"2867_CR46","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1093\/ndt\/gft033","volume":"28","author":"F Locatelli","year":"2013","unstructured":"Locatelli F, Barany P, Covic A, De Francisco A, Del Vecchio L, Goldsmith D, et al. Kidney disease: improving global outcomes guidelines on anaemia management in chronic kidney disease: a European renal best practice position statement. Nephrol, Dial, Transplant\u202f:Off Publ Euro Dial Trans Assoc\u2014Euro Ren Assoc. 2013;28(6):1346\u201359.","journal-title":"Nephrol, Dial, Transplant :Off Publ Euro Dial Trans Assoc\u2014Euro Ren Assoc"},{"key":"2867_CR47","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/ki.2012.270","volume":"82","author":"TB Drueke","year":"2012","unstructured":"Drueke TB, Parfrey PS. Summary of the KDIGO guideline on anemia and comment: reading between the (guide)line(s). Kidney Int. 2012;82:952\u201360.","journal-title":"Kidney Int"},{"key":"2867_CR48","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s10157-014-0948-3","volume":"18","author":"K Kimura","year":"2014","unstructured":"Kimura K. Preface: evidence-based clinical practice guidelines for CKD: an abridged English version. Clin Exp Nephrol. 2014;18:339\u201340.","journal-title":"Clin Exp Nephrol"},{"key":"2867_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10157-018-1648-1","volume":"23","author":"Japanese Society of N","year":"2019","unstructured":"Japanese Society of N. Essential points from evidence-based clinical practice guidelines for chronic kidney disease 2018. Clin Exp Nephrol. 2019;23:1\u201315.","journal-title":"Clin Exp Nephrol"},{"key":"2867_CR50","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10157-024-02497-4","volume":"28","author":"Japanese Society of N","year":"2024","unstructured":"Japanese Society of N. Essential points from evidence-based clinical practice guideline for chronic kidney disease 2023. Clin Exp Nephrol. 2024;28:473\u201395.","journal-title":"Clin Exp Nephrol"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-026-02867-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-026-02867-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-026-02867-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:03:05Z","timestamp":1782198185000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-026-02867-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2867"],"URL":"https:\/\/doi.org\/10.1007\/s10157-026-02867-0","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee at which the studies were conducted (No. 5118) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Passive informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}